Evidence for a Hydride/Dihydrogen Structure
A R T I C L E S
Spectral Data for BAr′4-. The 1H and 13C NMR resonances of the
BAr′4 (Ar′ ) 3,5-C6H3(CF3)2) counteranion in CD2Cl2 were essentially
invariant for all cationic complexes discussed here, and spectro-
scopic data are not repeated for each compound. 1H NMR (400 MHz,
CD2Cl2) δ 7.73 (s, 8 H, Ho), 7.57 (s, 4 H, Hp). 13C{1H} NMR (101
MHz, CD2Cl2) δ 161.9 (q, 1JC-B ) 49.8, Cipso), 135.0 (s, Co), 129.0 (q,
NaBAr′4 and sealed with a rubber stopper. The flask was placed in an
ice bath, and 5 mL of CH2Cl2 was introduced via syringe. The contents
of the flask were stirred for 10-15 min and then filtered through Celite
supported by a glass frit. The filtrate was concentrated in vacuo and
the flask placed in a freezer (243 K) for 2 d. Orange-red crystals of 4
(223 mg, 0.175 mmol) were isolated in 84% yield. Alternately, this
procedure can be repeated using 75 mg (0.206 mmol) of 11 and 191
mg (0.216 mmol) of NaBAr′4 to produce crystals of 4 (224 mg, 0.175
1
2JC-F ) 31.4, Cm), 124.7 (q, JC-F ) 272.6, CF3), 117.7 (s, Cp).
[Cp*(PMe3)Rh(H)(H2)]+BAr′4 (1). Solutions of complex 1 were
-
1
mmol) in 85% yield. H NMR (400 MHz, CD2Cl2, 273 K) δ 5.33 (s,
generated using the following three procedures. (a) An NMR tube was
charged with 5 mg (0.016 mmol) of 2 and sealed with a septum. The
tube was placed in a 233 K bath, and a solution of H(OEt2)2BAr′4 (32.0
mg, 0.032 mmol) in CD2Cl2 (0.5 mL) was added slowly via syringe.
The contents of the tube were allowed to warm briefly (2-3 min) to
room temperature and then cooled again in the 233 K bath. A 1H NMR
spectrum of the product revealed a mixture of approximately 90% 1
and 10% 3. (b) A J-Young NMR tube was charged with a solution of
4 (5-10 mg of 4 in 0.5 mL CD2Cl2), sealed, and attached to a vacuum
line. The sample was subjected to 4 freeze-pump-thaw cycles and
placed in a 233 K bath. The sample was then exposed to ∼1 atm H2,
the NMR tube was sealed, and complex 1 was formed by vigorous
shaking of the NMR tube. (c) In a third approach, 0.5 mL of CD2Cl2
or CDFCl2 was vacuum-transferred into a 5-mm NMR tube con-
taining 1-3 mg of 4. Upon thawing to 233 K the solution was ex-
posed to 1 atm H2 for several min to afford 1. The NMR tube was
then sealed under ∼500 Torr of H2 gas. As mentioned previously, 1
could not be isolated due to rapid decomposition upon removal of
solvent. However, solutions of 1 can be stored for long periods of time
4
2
CH2Cl2), 1.60 (d, JP-H ) 2.6 Hz, 15 H, Cp*), 1.44 (d, JP-H ) 10.1
Hz, 9 H, PMe3), 0.74 (d, JP-H ) 6.7 Hz, 3 H, Me). 31P{1H}
3
NMR (162 MHz, CD2Cl2, 273 K) δ 3.2 (d, 1JRh-P ) 163.6 Hz, PMe3).
13C{1H} NMR (101 MHz, CD2Cl2, 273 K) δ 101.5 (s, Cp*-Ar), 54.2
1
(s, CH2Cl2), 14.8 (d, JC-P ) 32.1 Hz, PMe3), 9.4 (s, Cp*-Me), 2.0
(dd, 1JC-Rh ) 24.7 Hz, 2JC-P ) 14.4 Hz, Me). Anal. Calcd for C47H41-
BF24Cl2PRh: C, 44.19; H, 3.24. Found: C, 44.21; H, 3.27. FAB
LRMS: m/z 329 ([Cp*(PMe3)Rh(Me)]+).
[Cp*(PMe3)Rh(H)(OH2)]+BAr′4- (5). A trace amount of complex
5 was formed in the reaction to generate 1. Residual H2O present in
the solvent and/or added H2 gas served to displace the labile η2-H2
1
ligand from 1, thereby forming 5. H NMR (400 MHz, CD2Cl2, 223
K) δ 1.72 (s, 15 H, Cp*), 1.45 (d, 2JP-H ) 13.4 Hz, 9 H, PMe3), -9.63
1
2
(dd, JRh-H ) 20.4 Hz, JP-H ) 45.1 Hz, 1 H, hydride).
Cp*(PMe3)Rh(Me)2 (8). In air, a Schlenk flask was charged with
200 mg (0.519 mmol) of 7 and sealed with a rubber stopper. The flask
was evacuated and back-filled with Ar 4×, and 10 mL of dry, degassed
Et2O was added via syringe. While stirring, 1.56 mmol (1.0 mL of a
1.5 M solution of MeLi in Et2O) of MeLi was added slowly via syringe.
The contents of the flask were stirred for 12 h after which ∼0.1 mL of
H2O was added to quench the MeLi. All liquids were cannula-filtered
into another Schlenk flask, and the volatile materials were removed in
vacuo to produce a brown solid. This solid was dissolved in pentane
and filtered through alumina. The light orange filtrate was collected
and the solvent removed in vacuo to produce 8 (114 mg, 0.332 mmol)
in 64% yield. Complex 8 has been previously characterized, but was
prepared using a different route.29
1
in a sealed vessel at 195 K or below. H NMR (400 MHz, CD2Cl2,
4
2
223 K) δ 1.92 (d, JP-H ) 2.7 Hz, 15 H, Cp*), 1.42 (d, JP-H ) 11.2
Hz, 9 H, PMe3), -7.95 (dd, 1JRh-H ) 24.6 Hz, 2JP-H ) 10.7 Hz, 3 H,
averaged H and η2-H2). 31P{1H} NMR (162 MHz, CD2Cl2, 223 K) δ
5.6 (d, JRh-P ) 122.8 Hz, PMe3). 13C{1H} NMR (101 MHz, CD2Cl2,
1
223 K) δ 104.1 (s, Cp*-Ar), 19.2 (d, 1JC-P ) 36.6 Hz, PMe3), 10.4 (s,
Cp*-Me).
Deuterium and Tritium Substitution in 1 (1-d1, 1-d2, 1-t1, and
1-t2). Deuterium was incorporated by freezing an NMR tube containing
a solution of 1, removing the H2 atmosphere, and replacing it with D2
gas. The NMR tube was then sealed under ∼500 Torr D2 gas. Tritiated
samples were obtained by exposing solutions of 1 to 150 Torr T2 at
-40 °C for 20-60 min, yielding 20-60% tritiation or 15-40 mCi of
activity. The apparatus for the safe manipulation of tritium has been
previously described.24 The samples were then frozen, the T2 was
removed, and the tube flame was sealed under vacuum.
Cp*(PMe3)Rh(Me)(OTf) (10). A Schlenk flask was charged with
100 mg (0.290 mmol) of 8 and 178 mg (0.290 mmol) of 9 and sealed
with a rubber stopper. The flask was placed in an ice bath, and 15 mL
of Et2O was introduced via syringe. The contents of the flask were
allowed to warm to rt while stirring. After 12 h of stirring the brown-
black solution was filtered through silanized silica gel and all solvent
removed in vacuo from the filtrate to produce an orange-brown solid.
This solid was recrystallized from Et2O/pentane to produce 10 (181
[(Cp*(PMe3)Rh(H))2(µ-H)]+BAr′4 (3). A Schlenk flask was
-
1
mg, 0.378 mmol) in 65% yield. H NMR (400 MHz, CD2Cl2, rt) δ
charged with 50.0 mg (0.158 mmol) of 2 and placed in a 233 K bath.
A cold (233 K) solution of H(OEt2)2BAr′4 (80.0 mg, 0.079 mmol) in
CH2Cl2 (4 mL) was cannula-transferred to the flask and the mixture
allowed to warm to room temperature. The orange solution was stirred
for 15-20 min and pentane (∼1 mL) was added via syringe. The flask
was placed in a freezer (243 K), and orange crystals of 3 (62.6 mg,
0.042 mmol, 53% yield) were isolated after a few days. 1H NMR (400
MHz, CD2Cl2, 193 K) δ 1.81 (s, 15 H, Cp*), 1.27 (d, 2JP-H ) 10.0 Hz,
9 H, PMe3), -14.91 (br s, 2 H, terminal H’s), -21.33 (br s, 1 H,
4
2
1.60 (d, JP-H ) 2.5 Hz, 15 H, Cp*), 1.45 (d, JP-H ) 10.3 Hz, 9 H,
PMe3), 0.83 (d, JP-H ) 6.9 Hz, 3 H, Me). 31P{1H} NMR (162 MHz,
3
CD2Cl2, RT) δ 6.7 (d, 1JRh-P ) 165.7 Hz, PMe3). 19F NMR (376 MHz,
CD2Cl2, RT) δ -79.1 (s). 13C{1H} NMR (101 MHz, CD2Cl2, RT) δ
1
1
119.7 (q, JC-F ) 320.2 Hz, CF3), 98.5 (s, Cp*-Ar), 14.6 (d, JC-P
30.1 Hz, PMe3), 9.5 (s, Cp*-Me), 4.2 (dd, JC-Rh ) 22.3 Hz, JC-P
)
)
1
2
16.5 Hz, Me).
Measurement of Activation Parameter Using NMR Line Broad-
ening Techniques. The activation barrier for exchange of a terminal
hydride with a bridging hydride in complex 3 was measured using
standard NMR line broadening experiments conducted at temperatures
between 163 and 223 K. Line widths (ν) were measured at half-height
in units of Hz and were corrected for line widths (νo) at the
low-temperature limit. The exchange rates were determined from the
equation k ) π(ν - νo). Free energies of activation were calculated
from the Eyring equation ∆G‡ ) -RT[ln(kh/kBT)].
Crystallographic Studies. Crystallographic studies were performed
by Dr. Peter S. White (complex 3) at the University of North Carolina,
Chapel Hill, Single-Crystal X-ray Facility or by Dr. Frederick J.
Hollander (complex 4) at the University of California, Berkeley, X-ray
Crystallography Facility.
1
4
bridging H). H NMR (400 MHz, CD2Cl2, 253 K) δ 1.90 (d, JP-H
)
2.8 Hz, 15 H, Cp*), 1.37 (d, 2JP-H ) 10.1 Hz, 9 H, PMe3), -16.99 (br
s; averaged signal for exchanging terminal and bridging H’s). 1H NMR
4
(400 MHz, CD2Cl2, 313 K) δ 1.95 (d, JP-H ) 2.8 Hz, 15 H, Cp*),
2
1
1.43 (d, JP-H ) 10.1 Hz, 9 H, PMe3), -16.99 (tt, JRh-H ) 14.4 Hz,
2JP-H ) 20.0 Hz, 3 H, signal for rapidly exchanging terminal and
bridging H’s). 31P{1H} NMR (162 MHz, CD2Cl2, 253 K) δ 4.5 (d,
1JRh-P ) 137.4 Hz, PMe3). 13C{1H} NMR (101 MHz, CD2Cl2, 253
1
K) δ 100.2 (s, Cp*-Ar), 21.1 (d, JC-P ) 34.1 Hz, PMe3), 11.6 (s,
Cp*-Me). Anal. Calcd for C58H63BF24P2Rh2: C, 46.61; H, 4.25.
Found: C, 46.49; H, 4.23.
[Cp*(PMe3)Rh(Me)(CH2Cl2)]+BAr′4 (4). A Schlenk flask was
-
charged with 100 mg (0.209 mmol) of 10 and 94 mg (0.220 mmol) of
9
J. AM. CHEM. SOC. VOL. 124, NO. 18, 2002 5107